Effects e O
of O O
docosahexaenoic o O
acid d O
and 	 O
methylmercury h O
on O O
child l O
' 
 O
s 
 O
brain i O
development e O
due 	 O
to O O
consumption s O
of O O
fish h O
by O O
Finnish n O
mother h O
during i O
pregnancy g O
: 
 O
a 
 O
probabilistic b O
modeling e O
approach r O
. 
 O
Fish h O
contains t O
both h O
beneficial e O
substances s O
e 
 O
. 
 O
g 
 O
. 
 O
docosahexaenoic o O
acids d O
but 	 O
also o O
harmful m O
compounds p O
e 
 O
. 
 O
g 
 O
. 
 O
methylmercury h O
. 
 O
Importantly o O
, 
 O
the 	 O
health l O
effects e O
caused s O
by O O
these s O
two 	 O
substances s O
can 	 O
be O O
evaluated l O
in O O
one 	 O
common m O
end 	 O
point n O
, 
 O
intelligence e O
quotient t O
( 
 O
IQ O O
) 
 O
, 
 O
providing v O
a 
 O
more e O
transparent n O
analysis l O
. 
 O
We O O
estimated i O
health l O
effects e O
of O O
maternal e O
fish h O
consumption s O
on O O
child l O
' 
 O
s 
 O
central t O
nervous v O
system t O
by O O
creating a O
a 
 O
model e O
with h O
three e O
alternative e O
maternal e O
fish h O
consumption s O
scenarios n O
( 
 O
lean n O
fish h O
, 
 O
fatty t O
fish h O
, 
 O
and 	 O
current r O
fish h O
consumption s O
) 
 O
. 
 O
Additionally i O
, 
 O
we O O
analyzed l O
impacts a O
of O O
both h O
regular u O
fish h O
consumption s O
and 	 O
extreme r O
fish h O
consumption s O
habits i O
. 
 O
At O O
the 	 O
individual i O
level e O
, 
 O
the 	 O
simulated u O
net 	 O
effects e O
were e O
small l O
, 
 O
encompassing o O
a 
 O
range g O
of O O
one 	 O
IQ O O
point n O
in O O
all 	 O
scenarios n O
. 
 O
Fatty t O
fish h O
consumption s O
, 
 O
however e O
, 
 O
clearly a O
generated e O
a 
 O
beneficial e O
net 	 O
IQ O O
effect e O
, 
 O
and 	 O
lean n O
fish h O
consumption s O
evoked k O
an O O
adverse e O
net 	 O
IQ O O
effect e O
. 
 O
In O O
view w O
of O O
the 	 O
current r O
fish h O
consumption s O
pattern t O
of O O
Finnish n O
mothers h O
the 	 O
benefits e O
and 	 O
risks k O
seem m O
to O O
more e O
or O O
less s O
compensate p O
each h O
other e O
. 
 O
This s O
study d O
clearly a O
shows w O
the 	 O
significance n O
of O O
which c O
fish h O
species c O
are 	 O
consumed s O
during i O
pregnancy g O
and 	 O
lactation t O
, 
 O
and 	 O
the 	 O
results u O
can 	 O
be O O
generalized e O
to O O
apply l O
to O O
typical i O
western t O
population u O
fish h O
consumption s O
habits i O
. 
 O
The 	 O
mechanisms h O
responsible p O
for 	 O
garlic l O
- 
 O
drug g O
interactions e O
and 	 O
their i O
in O O
vivo o O
relevance e O
. 
 O
Garlic l O
phytochemicals t O
and 	 O
garlic l O
supplements p O
influence l O
the 	 O
pharmacokinetic r O
and 	 O
pharmacodynamic r O
behavior a O
of O O
concomitantly c O
ingested e O
drugs g O
. 
 O
In O O
this s O
paper e O
we O O
have e O
summarized m O
the 	 O
mechanisms h O
responsible p O
for 	 O
first s O
- 
 O
pass s O
intestinal e O
pharmacokinetic r O
interactions e O
by O O
investigating e O
the 	 O
intestinal e O
permeability m O
of O O
some e O
cardiovascular d O
, 
 O
antiviral i O
drugs g O
, 
 O
their i O
transport n O
with h O
hepatic a O
transporters n O
and 	 O
CYP3A4 3 O
metabolism a O
. 
 O
Transporter n O
- 
 O
enzyme y O
interplay e O
was 	 O
studied d O
with h O
several e O
in O O
vitro r O
models e O
of O O
varying y O
complexity p O
: 
 O
rat 	 O
small l O
intestine e O
and 	 O
Caco o O
- 
 O
2 
 O
cell l O
monolayers o O
were e O
used d O
in O O
studies d O
of O O
intestinal e O
processes c O
, 
 O
and 	 O
hepatic a O
pharmacokinetics r O
was 	 O
monitored i O
in O O
HepG2 G O
cells l O
, 
 O
isolated l O
rat 	 O
hepatocytes a O
and 	 O
rat 	 O
liver e O
slices c O
. 
 O
Garlic l O
phytochemicals t O
from m O
aged d O
garlic l O
extract r O
modified i O
the 	 O
activities i O
of O O
secretory r O
and 	 O
absorptive o O
transporters n O
in O O
both h O
intestine e O
and 	 O
liver e O
and 	 O
competitively p O
inhibited i O
CYP3A4 3 O
enzyme y O
. 
 O
The 	 O
increased r O
activities i O
of O O
the 	 O
most t O
important o O
intestinal e O
efflux l O
( 
 O
P 
 O
- 
 O
glycoprotein c O
- 
 O
Pgp 	 O
, 
 O
Multidrug t O
Resistance i O
Associated o O
Protein t O
2 
 O
- 
 O
MRP 	 O
- 
 O
2 
 O
, 
 O
Breast a O
Cancer c O
Resistance i O
Protein t O
- 
 O
BCRP P O
) 
 O
and 	 O
uptake a O
( 
 O
MonoCarboxylate o O
Transporter n O
1 
 O
- 
 O
MCT1 1 O
, 
 O
Organic a O
Anion o O
Transporting n O
Polypeptide y O
- 
 O
OATP P O
, 
 O
Peptide t O
transporter n O
1 
 O
- 
 O
PepT1 T O
) 
 O
transporters n O
were e O
caused s O
by O O
changes n O
in O O
electrophysiological c O
membrane b O
properties p O
and 	 O
by O O
allosteric o O
modifications i O
. 
 O
Because a O
clinical n O
studies d O
investigating e O
interactions e O
between w O
garlic l O
and 	 O
human a O
immunodeficiency u O
virus u O
protease t O
inhibitors i O
saquinavir u O
and 	 O
ritonavir o O
have e O
already e O
been n O
performed f O
, 
 O
we O O
used d O
these s O
in O O
vivo o O
data a O
to O O
evaluate l O
the 	 O
in O O
vitro r O
results u O
and 	 O
the 	 O
reliability i O
of O O
the 	 O
models e O
employed l O
as O O
screening e O
tools l O
for 	 O
forecasting e O
the 	 O
potential e O
of O O
first s O
- 
 O
pass s O
intestinal e O
metabolism a O
changes n O
. 
 O
We O O
also o O
assessed e O
the 	 O
probability b O
of O O
pharmacokinetic r O
interactions e O
with h O
garlic l O
of O O
the 	 O
novel e O
drug g O
darunavir u O
and 	 O
other e O
cardiovascular d O
drugs g O
. 
 O
Finally a O
, 
 O
selected e O
garlic l O
phytochemicals t O
were e O
tested t O
for 	 O
their i O
ability l O
to O O
influence l O
P 
 O
- 
 O
glycoprotein c O
and 	 O
CYP3A4 3 O
activities i O
. 
 O
Endothelial o O
nitric r O
oxide d O
synthase t O
genotypes o O
and 	 O
haplotypes l O
modify i O
the 	 O
responses p O
to O O
sildenafil d O
in O O
patients i O
with h O
erectile c O
dysfunction f O
. 
 O
Erectile c O
dysfunction f O
( 
 O
ED O O
) 
 O
is O O
usually a O
treated a O
with h O
sildenafil d O
. 
 O
Although h O
genetic e O
polymorphisms y O
in O O
the 	 O
endothelial o O
nitric r O
oxide d O
synthase t O
( 
 O
eNOS S O
) 
 O
gene e O
may 	 O
impair a O
endogenous o O
NO S O
formation m O
, 
 O
there r O
is O O
little t O
information o O
about u O
how 	 O
eNOS S O
polymorphisms y O
and 	 O
haplotypes l O
affect e O
the 	 O
responses p O
to O O
sildenafil d O
. 
 O
We O O
studied d O
118 	 O
patients i O
; 
 O
63 O O
patients i O
had 	 O
ED O O
secondary o O
to O O
radical i O
prostatectomy s O
( 
 O
PED 	 O
) 
 O
and 	 O
55 O O
had 	 O
organic a O
, 
 O
clinical n O
ED O O
. 
 O
eNOS S O
genotypes o O
for 	 O
three e O
eNOS S O
polymorphisms y O
( 
 O
T 
 O
( 
 O
- 
 O
786 	 O
) 
 O
C 
 O
, 
 O
rs2070744 0 O
; 
 O
a 
 O
variable i O
number b O
of O O
tandem d O
repeats e O
( 
 O
VNTR R O
) 
 O
in O O
intron r O
4 
 O
; 
 O
and 	 O
Glu298Asp 2 O
, 
 O
rs1799983 7 O
) 
 O
were e O
determined e O
, 
 O
and 	 O
eNOS S O
haplotypes l O
were e O
estimated i O
using n O
PHASE S O
2 
 O
. 
 O
1 
 O
. 
 O
The 	 O
clinical n O
responses p O
to O O
sildenafil d O
were e O
evaluated l O
and 	 O
the 	 O
patients i O
were e O
classified s O
as O O
good d O
responders p O
( 
 O
GR O O
) 
 O
or O O
poor r O
responders p O
( 
 O
PR O O
) 
 O
when n O
their i O
changes n O
in O O
five e O
- 
 O
item m O
version s O
of O O
International e O
Index e O
for 	 O
Erectile c O
Function c O
questionnaire s O
were e O
above v O
or O O
below o O
the 	 O
median i O
value u O
. 
 O
The 	 O
TC O O
/ 
 O
CC O O
genotypes o O
and 	 O
the 	 O
C 
 O
allele e O
for 	 O
the 	 O
T 
 O
( 
 O
- 
 O
786 	 O
) 
 O
C 
 O
polymorphism y O
were e O
more e O
common m O
in O O
GR O O
, 
 O
compared p O
with h O
PR O O
patients i O
with h O
PED 	 O
. 
 O
However e O
, 
 O
the 	 O
4b4a a O
/ 
 O
4a4a a O
genotypes o O
and 	 O
the 	 O
4a O O
allele e O
for 	 O
the 	 O
VNTR R O
polymorphism y O
in O O
intron r O
4 
 O
were e O
more e O
common m O
in O O
GR O O
, 
 O
compared p O
with h O
PR O O
patients i O
with h O
clinical n O
ED O O
. 
 O
The 	 O
C 
 O
- 
 O
4a O O
- 
 O
Glu 	 O
haplotype l O
was 	 O
more e O
common m O
in O O
GR O O
than n O
in O O
PR O O
patients i O
with h O
PED 	 O
. 
 O
Conversely v O
, 
 O
the 	 O
T 
 O
- 
 O
4b O O
- 
 O
Asp 	 O
haplotype l O
was 	 O
less s O
common m O
in O O
GR O O
than n O
in O O
PR O O
patients i O
with h O
PED 	 O
. 
 O
No O O
other e O
significant n O
differences f O
were e O
found n O
. 
 O
Our 	 O
findings d O
show w O
evidence d O
that t O
eNOS S O
polymorphisms y O
affect e O
the 	 O
responses p O
of O O
PED 	 O
and 	 O
clinical n O
ED O O
patients i O
to O O
sildenafil d O
. 
 O
On O O
the 	 O
benefit e O
of O O
magnetic n O
magnesium n O
nanocarrier o O
in O O
cardiovascular d O
toxicity i O
of O O
aluminum m O
phosphide s O
. 
 O
The 	 O
present s O
study d O
was 	 O
designed i O
to O O
determine e O
the 	 O
effect e O
of O O
a 
 O
new 	 O
( - O
25 I O
) - O
Mg I O
( - O
2 - O
+ - O
) - O
- 
 O
carrying r O
nanoparticle o O
( 
 O
( - O
25 I O
) - O
MgPMC16 M O
) 
 O
on O O
energy r O
depletion l O
, 
 O
oxidative d O
stress e O
, 
 O
and 	 O
electrocardiographic c O
( 
 O
ECG 	 O
) 
 O
parameters a O
on O O
heart r O
tissue s O
of O O
the 	 O
rats s O
poisoned s O
by O O
aluminum m O
phosphide s O
( 
 O
AlP 	 O
) 
 O
. 
 O
( - O
25 I O
) - O
MgPMC16 M O
at O O
doses e O
of O O
0 
 O
. 
 O
025 	 O
, 
 O
0 
 O
. 
 O
05 O O
, 
 O
and 	 O
0 
 O
. 
 O
1 
 O
median i O
lethal h O
dose e O
( 
 O
LD50 0 O
= 
 O
896 	 O
mg O O
/ 
 O
kg O O
) 
 O
was 	 O
administered i O
intravenously r O
( 
 O
iv O O
) 
 O
30 O O
min 	 O
after e O
a 
 O
single g O
intragastric r O
administration i O
of O O
AlP 	 O
( 
 O
0 
 O
. 
 O
25 O O
LD50 0 O
) 
 O
. 
 O
Sodium i O
bicarbonate a O
( 
 O
Bicarb a O
; 
 O
2 
 O
mEq 	 O
/ 
 O
kg O O
, 
 O
iv O O
) 
 O
was 	 O
used d O
as O O
the 	 O
standard n O
therapy r O
. 
 O
After e O
anesthesia s O
, 
 O
the 	 O
animals m O
were e O
rapidly i O
connected n O
to O O
an O O
electronic c O
cardiovascular d O
monitoring i O
device i O
for 	 O
monitoring i O
of O O
ECG 	 O
, 
 O
blood o O
pressure s O
( 
 O
BP O O
) 
 O
, 
 O
and 	 O
heart r O
rate e O
( 
 O
HR O O
) 
 O
. 
 O
Later e O
lipid i O
peroxidation o O
, 
 O
antioxidant i O
power e O
, 
 O
ATP 	 O
/ 
 O
ADP 	 O
ratio i O
, 
 O
and 	 O
Mg S O
concentration c O
in O O
the 	 O
heart r O
were e O
evaluated l O
. 
 O
Results u O
indicated i O
that t O
after e O
AlP 	 O
administration i O
, 
 O
BP O O
and 	 O
HR O O
decreased r O
while l O
R 
 O
- 
 O
R 
 O
duration a O
increased r O
. 
 O
( - O
25 I O
) - O
MgPMC16 M O
significantly n O
increased r O
the 	 O
BP O O
and 	 O
HR O O
at O O
all 	 O
doses e O
used d O
. 
 O
We O O
found n O
a 
 O
considerable s O
increase r O
in O O
antioxidant i O
power e O
, 
 O
Mg S O
level e O
in O O
the 	 O
plasma s O
and 	 O
the 	 O
heart r O
and 	 O
a 
 O
reduction u O
in O O
lipid i O
peroxidation o O
and 	 O
ADP 	 O
/ 
 O
ATP 	 O
ratio i O
at O O
various i O
doses e O
of O O
( - O
25 I O
) - O
MgPMC16 M O
, 
 O
but 	 O
( - O
25 I O
) - O
MgPMC16 M O
- 
 O
0 
 O
. 
 O
025 	 O
+ 
 O
Bicarb a O
was 	 O
the 	 O
most t O
effective e O
combination b O
therapy r O
. 
 O
The 	 O
results u O
of O O
this s O
study d O
support p O
that t O
( - O
25 I O
) - O
MgPMC16 M O
can 	 O
increase r O
heart r O
energy r O
by O O
active i O
transport n O
of O O
Mg S O
inside i O
the 	 O
cardiac d O
cells l O
. 
 O
( - O
25 I O
) - O
MgPMC16 M O
seems m O
ameliorating l O
AlP 	 O
- 
 O
induced u O
toxicity i O
and 	 O
cardiac d O
failure l O
necessitating e O
further t O
studies d O
. 
 O
Ventilatory t O
functions c O
in O O
cotton t O
textile t O
workers k O
and 	 O
the 	 O
role e O
of O O
some e O
inflammatory l O
cytokines o O
. 
 O
Exposure o O
to O O
cotton t O
dust t O
in O O
industrial u O
environments i O
causes s O
inflammation l O
in O O
the 	 O
airways w O
of O O
the 	 O
exposed o O
workers k O
. 
 O
This s O
may 	 O
manifest i O
as O O
respiratory p O
complaints p O
and 	 O
changes n O
in O O
the 	 O
respiratory p O
functions c O
after e O
work k O
shift f O
and 	 O
in O O
the 	 O
baseline e O
of O O
their i O
ventilatory t O
functions c O
. 
 O
The 	 O
study d O
aimed e O
to O O
investigate e O
the 	 O
effect e O
of O O
occupational u O
exposure o O
to O O
cotton t O
dust t O
on O O
respiratory p O
symptoms p O
, 
 O
ventilatory t O
functions c O
and 	 O
pro 	 O
- 
 O
inflammatory l O
cytokine o O
levels e O
( 
 O
tumor o O
necrosis r O
factor t O
alpha h O
, 
 O
interleukin e O
6 
 O
and 	 O
interleukin e O
1 
 O
beta a O
) 
 O
. 
 O
The 	 O
study d O
was 	 O
conducted d O
on O O
63 O O
textile t O
workers k O
and 	 O
65 O O
nonexposed e O
subjects j O
. 
 O
Both h O
groups u O
were e O
matched c O
for 	 O
age 	 O
, 
 O
socioeconomic i O
status t O
and 	 O
smoking k O
habit i O
. 
 O
The 	 O
respirable p O
dust t O
measured s O
in O O
the 	 O
workplace k O
did 	 O
not 	 O
exceed e O
the 	 O
permissible m O
values u O
of O O
the 	 O
Egyptian p O
law 	 O
1994 4 O
. 
 O
The 	 O
bacterial t O
counts n O
detected e O
were e O
within h O
the 	 O
occupational u O
exposure o O
limits i O
of O O
the 	 O
industrial u O
settings t O
. 
 O
The 	 O
results u O
revealed e O
that t O
the 	 O
percentage c O
of O O
respiratory p O
symptoms p O
was 	 O
higher h O
in O O
textile t O
workers k O
. 
 O
Respiratory p O
complaints p O
were e O
chronic o O
cough g O
( 
 O
33 O O
. 
 O
2 
 O
% 
 O
) 
 O
, 
 O
chronic o O
bronchitis n O
( 
 O
39 O O
. 
 O
7 
 O
% 
 O
) 
 O
and 	 O
dyspnea p O
( 
 O
23 O O
. 
 O
8 
 O
% 
 O
) 
 O
in O O
textile t O
workers k O
compared p O
to O O
( 
 O
6 
 O
. 
 O
2 
 O
% 
 O
, 
 O
6 
 O
. 
 O
2 
 O
% 
 O
and 	 O
1 
 O
. 
 O
5 
 O
% 
 O
) 
 O
, 
 O
respectively p O
, 
 O
in O O
controls t O
. 
 O
There r O
was 	 O
a 
 O
marked k O
reduction u O
in O O
the 	 O
ventilatory t O
functions c O
( 
 O
forced c O
vital a O
capacity a O
and 	 O
forced c O
expiratory i O
volume u O
in O O
1 
 O
s 
 O
) 
 O
in O O
the 	 O
textile t O
workers k O
compared p O
to O O
the 	 O
controls t O
. 
 O
The 	 O
additive i O
effect e O
of O O
smoking k O
on O O
the 	 O
ventilatory t O
functions c O
was 	 O
not 	 O
apparent a O
. 
 O
The 	 O
ventilatory t O
functions c O
of O O
the 	 O
workers k O
were e O
significantly n O
positively i O
correlated r O
with h O
the 	 O
duration a O
of O O
exposure o O
. 
 O
The 	 O
cytokines o O
were e O
insignificantly i O
higher h O
in O O
the 	 O
textile t O
workers k O
compared p O
to O O
their i O
controls t O
. 
 O
The 	 O
textile t O
workers k O
with h O
respiratory p O
complaints p O
showed w O
significant n O
decline l O
in O O
ventilatory t O
functions c O
and 	 O
elevation v O
in O O
the 	 O
cytokine o O
levels e O
compared p O
to O O
the 	 O
nonsymtomatizing s O
workers k O
with h O
significant n O
difference f O
in O O
interleukin e O
1 
 O
beta a O
and 	 O
interleukin e O
6 
 O
. 
 O
In O O
conclusion c O
, 
 O
the 	 O
results u O
supported p O
the 	 O
fact t O
that t O
exposure o O
to O O
cotton t O
dust t O
deteriorates e O
ventilatory t O
functions c O
and 	 O
elevates v O
proinflammatory i O
cytokine o O
levels e O
. 
 O
Analysis l O
of O O
the 	 O
release e O
of O O
cytokines o O
can 	 O
be O O
used d O
to O O
evaluate l O
the 	 O
immune u O
responses p O
to O O
organic a O
dust t O
- 
 O
induced u O
airway w O
inflammation l O
. 
 O
Heat t O
stress e O
decreases r O
testicular t O
germ m O
cell l O
proliferation l O
and 	 O
increases r O
apoptosis p O
in O O
short r O
term m O
: 
 O
an O O
immunohistochemical u O
and 	 O
ultrastructural r O
study d O
. 
 O
Scrotal o O
hyperthermia e O
has 	 O
been n O
known w O
as O O
a 
 O
cause s O
of O O
male e O
infertility e O
but 	 O
the 	 O
exact c O
mechanism h O
leading d O
to O O
impaired a O
spermatogenesis r O
is O O
unknown n O
. 
 O
This s O
work k O
was 	 O
aimed e O
to O O
investigate e O
the 	 O
role e O
of O O
scrotal o O
hyperthermia e O
on O O
cell l O
proliferation l O
and 	 O
apoptosis p O
in O O
testes t O
. 
 O
The 	 O
rats s O
were e O
randomly d O
allotted o O
into o O
one 	 O
of O O
the 	 O
four r O
experimental e O
groups u O
: 
 O
A 
 O
( 
 O
control t O
) 
 O
, 
 O
B 
 O
( 
 O
1 
 O
day 	 O
after e O
scrotal o O
hyperthermia e O
) 
 O
, 
 O
C 
 O
( 
 O
14 O O
days s O
after e O
scrotal o O
hyperthermia e O
) 
 O
, 
 O
and 	 O
D 
 O
( 
 O
35 O O
days s O
after e O
scrotal o O
hyperthermia e O
) 
 O
; 
 O
each h O
group u O
comprised p O
7 
 O
animals m O
. 
 O
Scrotal o O
hyperthermia e O
was 	 O
carried r O
out 	 O
in O O
a 
 O
thermostatically r O
controlled t O
water e O
bath h O
at O O
43 O O
degrees r O
C 
 O
for 	 O
30 O O
min 	 O
once e O
daily l O
for 	 O
6 
 O
consecutive s O
days s O
. 
 O
Control t O
rats s O
were e O
treated a O
in O O
the 	 O
same e O
way 	 O
, 
 O
except e O
the 	 O
testes t O
were e O
immersed e O
in O O
a 
 O
water e O
bath h O
maintained n O
at O O
22 O O
degrees r O
C 
 O
. 
 O
Hyperthermia e O
- 
 O
exposed o O
rats s O
were e O
killed l O
under e O
50 O O
mg O O
/ 
 O
kg O O
ketamine a O
anaesthesia e O
and 	 O
tissue s O
samples p O
were e O
obtained a O
for 	 O
biochemical c O
and 	 O
histopathological t O
investigations e O
. 
 O
Hyperthermia e O
treatment a O
significantly n O
decreased r O
the 	 O
testicular t O
antioxidant i O
system t O
, 
 O
including l O
decreases r O
in O O
the 	 O
glutathione t O
level e O
, 
 O
superoxide e O
dismutase m O
, 
 O
and 	 O
glutathione t O
peroxidase o O
activities i O
. 
 O
Moreover e O
, 
 O
exposure o O
to O O
hyperthermia e O
resulted u O
in O O
lipid i O
peroxidation o O
increase r O
in O O
testes t O
. 
 O
Our 	 O
data a O
indicate i O
a 
 O
significant n O
reduction u O
in O O
the 	 O
expression r O
of O O
proliferating l O
cell l O
nuclear l O
antigen i O
and 	 O
an O O
enhancement a O
in O O
the 	 O
activity i O
of O O
terminal m O
deoxynucleotidyl x O
transferase n O
dUTP P O
nick k O
end 	 O
labelling e O
after e O
scrotal o O
hyperthermia e O
. 
 O
In O O
scrotal o O
hyperthermia e O
, 
 O
the 	 O
mitochondrial o O
degeneration e O
, 
 O
dilatation a O
of O O
smooth o O
endoplasmic o O
reticulum i O
, 
 O
and 	 O
enlarged a O
intercellular e O
spaces c O
were e O
observed e O
in O O
both h O
Sertoli t O
and 	 O
spermatid r O
cells l O
. 
 O
Scrotal o O
hyperthermia e O
is O O
one 	 O
of O O
the 	 O
major o O
factors t O
that t O
impair a O
spermatogenesis r O
in O O
testis t O
. 
 O
This s O
heat t O
stress e O
is O O
shown w O
to O O
be O O
closely s O
associated o O
with h O
oxidative d O
stress e O
, 
 O
followed l O
by O O
apoptosis p O
of O O
germ m O
cells l O
. 
 O
A 
 O
genomic o O
approach r O
to O O
predict d O
synergistic e O
combinations b O
for 	 O
breast a O
cancer c O
treatment a O
. 
 O
We O O
leverage e O
genomic o O
and 	 O
biochemical c O
data a O
to O O
identify n O
synergistic e O
drug g O
regimens i O
for 	 O
breast a O
cancer c O
. 
 O
In O O
order e O
to O O
study d O
the 	 O
mechanism h O
of O O
the 	 O
histone t O
deacetylase c O
( 
 O
HDAC C O
) 
 O
inhibitors i O
valproic p O
acid d O
( 
 O
VPA 	 O
) 
 O
and 	 O
suberoylanilide e O
hydroxamic r O
acid d O
( 
 O
SAHA A O
) 
 O
in O O
breast a O
cancer c O
, 
 O
